Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta O-thalassemia intermedia.

G Cividalli, H Kerem, E Ezeckiel

    Blood
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Beta O-thalassemia severity is not linked to peripheral blood globin chain imbalance. Instead, it depends on bone marrow cell synthesis ratios, where most hemoglobin production occurs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selective toxicity towards myelodysplastic hematopoietic progenitors - another rationale for iron chelation in MDS.

    Leukemia research·2012
    Same author

    Evaluating the impact of age and disease on survival of chronic lymphocytic leukaemia patients by a new method.

    International journal of clinical practice·2009
    Same author

    Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.

    QJM : monthly journal of the Association of Physicians·2008
    Same author

    Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes.

    Bone marrow transplantation·2002
    Same author

    Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.

    Cancer chemotherapy and pharmacology·2001
    Same author

    Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.

    Reviews in clinical and experimental hematology·2001
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Area of Science:

    • Hematology
    • Molecular Biology
    • Genetics

    Background:

    • Beta O-thalassemia is a genetic blood disorder characterized by reduced or absent beta-globin synthesis.
    • Clinical severity varies, with some patients requiring regular blood transfusions while others have milder forms.

    Purpose of the Study:

    • To investigate the relationship between globin chain synthesis imbalance and clinical severity in beta O-thalassemia.
    • To compare globin synthesis ratios in peripheral blood and bone marrow cells of patients with mild beta O-thalassemia.

    Main Methods:

    • Studied three patients with mild beta O-thalassemia.
    • Analyzed globin synthesis using gel filtration and urea-carboxymethylcellulose chromatography.
    • Measured gamma/alpha synthetic ratios in peripheral blood and bone marrow cells.

    Related Experiment Videos

  • Assessed free alpha-chain pool size.

    • Main Results:

    • Peripheral blood gamma/alpha synthetic ratios were similar to severe beta O-thalassemia cases.
    • Bone marrow cell gamma/alpha synthetic ratios were higher in mild cases compared to severe cases.
    • The free alpha-chain pool size was smaller in one mild case compared to severe Cooley anemia.

    Conclusions:

    • Clinical severity in beta O-thalassemia does not correlate with peripheral blood alpha/gamma chain synthesis imbalance.
    • The synthetic ratio in bone marrow cells, the primary site of hemoglobin synthesis, determines clinical outcome.